Sunshine Act Meeting, 70149 [2020-24560]
Download as PDF
<![CDATA[
Federal Register / Vol. 85, No. 214 / Wednesday, November 4, 2020 / Notices
through risk management measures
enumerated in 15 U.S.C. 2605(a).
EPA also is announcing the
availability of the information required
to be provided publicly with each risk
evaluation, which is available online at
https://www.regulations.gov in the
dockets identified. 40 CFR 702.51.
Specifically, EPA has provided:
• The scope document and problem
formulation (in Docket ID No. EPA–HQ–
OPPT–2016–0733);
• Draft risk evaluation, and final risk
evaluation (in Docket ID No. EPA–HQ–
OPPT–2019–0499);
• All notices, determinations,
findings, consent agreements, and
orders (in Docket ID No. EPA–HQ–
OPPT–2019–0499);
• Any information required to be
provided to the Agency under 15 U.S.C.
2603 (in Docket ID No. EPA–HQ–OPPT–
2016–0733 and Docket ID No. EPA–HQ–
OPPT–2019–0499);
• A nontechnical summary of the risk
evaluation (in Docket ID No. EPA–HQ–
OPPT–2019–0499);
• A list of the studies, with the results
of the studies, considered in carrying
out each risk evaluation (Risk
Evaluation for Carbon Tetrachloride
(CCl4)) in Docket ID No. EPA–HQ–
OPPT–2019–0499);
• The final peer review report,
including the response to peer review
and public comments received during
peer review (in Docket ID No. EPA–HQ–
OPPT–2019–0499); and
• Response to public comments
received on the draft scope and the draft
risk evaluation (in Docket ID No. EPA–
HQ–OPPT–2019–0499).
II. TSCA Risk Evaluation
khammond on DSKJM1Z7X2PROD with NOTICES
A. What is EPA’s risk evaluation process
for existing chemicals under TSCA?
The risk evaluation process is the
second step in EPA’s existing chemical
review process under TSCA, following
prioritization and before risk
management. As this chemical is one of
the first ten chemical substances
undergoing risk evaluation, the
chemical substance was not required to
go through prioritization (81 FR 91927,
December 19, 2016) (FRL–9956–47). The
purpose of conducting risk evaluations
is to determine whether a chemical
substance presents an unreasonable risk
of injury to health or the environment
under the conditions of use, including
an unreasonable risk to a relevant
potentially exposed or susceptible
subpopulation. As part of this process,
EPA must evaluate both hazard and
exposure, not consider costs or other
nonrisk factors, use reasonably available
information and approaches in a
VerDate Sep<11>2014
18:16 Nov 03, 2020
Jkt 253001
manner that is consistent with the
requirements in TSCA for the use of the
best available science, and ensure
decisions are based on the weight of the
scientific evidence.
The specific risk evaluation process
that EPA has established by rule to
implement the statutory process is set
out in 40 CFR part 702 and summarized
on EPA’s website at https://
www.epa.gov/assessing-and-managingchemicals-under-tsca/risk-evaluationsexisting-chemicals-under-tsca. As
explained in the preamble to EPA’s final
rule on procedures for risk evaluation
(82 FR 33726, July 20, 2017) (FRL–
9964–38), the specific regulatory
process set out in 40 CFR part 702,
subpart B is being followed for the first
ten chemical substances undergoing risk
evaluation to the maximum extent
practicable.
Prior to the publication of this final
risk evaluation, a draft risk evaluation
was subject to peer review and public
comment. EPA reviewed the report from
the peer review committee and public
comments and has amended the risk
evaluation in response to these
comments as appropriate. The public
comments, peer review report, and
EPA’s response to comments is in
Docket ID No. EPA–HQ–OPPT–2019–
0499. Prior to the publication of the
draft risk evaluation, EPA made
available the scope and problem
formulation, and solicited public input
on uses and exposure. EPA’s documents
and the public comments are in Docket
ID No. EPA–HQ–OPPT–2016–0733.
Additionally, information about the
scope, problem formulation, and draft
risk evaluation phases of the TSCA risk
evaluation for this chemical is available
at EPA’s website at https://
www.epa.gov/assessing-and-managingchemicals-under-tsca/risk-evaluationcarbon-tetrachloride.
B. What is carbon tetrachloride (CCl4)?
Carbon tetrachloride (CCl4) is used as
a feedstock in the production of
hydrochloro fluorocarbons (HCFCs),
hydrofluorocarbons (HFCs) and
hydrofluoroolefins (HFOs), and is a
high-production volume solvent. It is
also used as a process agent in the
manufacturing of petrochemicalsderived and agricultural products and
other chlorinated compounds such as
chlorinated paraffins, chlorinated
rubber and others that may be used
downstream in the formulation of
solvents for degreasing and cleaning,
adhesives, sealants, paints, coatings,
rubber, cement and asphalt
formulations.
PO 00000
Frm 00023
Fmt 4703
Sfmt 4703
70149
Authority: 15 U.S.C. 2601 et seq.
Andrew Wheeler,
Administrator.
[FR Doc. 2020–24478 Filed 11–3–20; 8:45 am]
BILLING CODE 6560–50–P
EQUAL EMPLOYMENT OPPORTUNITY
COMMMISSION
Sunshine Act Meeting
Monday, November 9,
2020, 1:00 p.m. Eastern Time.
PLACE: Because of the COVID–19
pandemic, the meeting will be held as
an audio-only conference.
STATUS: The meeting will be open to the
public.
MATTERS TO BE CONSIDERED: The
following item will be considered at the
meeting:
Update to the Compliance Manual
Section on Religious Discrimination.
DATE AND TIME:
Note: (In addition to publishing notices on
EEOC Commission meetings in the Federal
Register, the Commission also provides
information about Commission meetings on
its website, www.eeoc.gov., and provides a
recorded announcement a week in advance
on future Commission sessions.)
Please telephone (202) 663–7100
(voice) or email
commissionmeetingcomments@eeoc.gov
at any time for information on this
meeting.
CONTACT PERSON FOR MORE INFORMATION:
Bernadette B. Wilson, Executive Officer
on (202) 663–4077.
Raymond L. Peeler,
Assistant Legal Counsel, Office of Legal
Counsel.
[FR Doc. 2020–24560 Filed 11–2–20; 11:15 am]
BILLING CODE 6570–01–P
EXPORT-IMPORT BANK
Sunshine Act Meetings; Notice of
Open Meeting of the Sub-Saharan
Africa Advisory Committee of the
Export-Import Bank of the United
States (EXIM)
Tuesday, November 17,
2020 from 2:00–4:00 p.m. EST.
PLACE: The meeting will be held
virtually.
STATUS: Public Participation: The
meeting will be open to public
participation and time will be allotted
for questions or comments submitted
online. Members of the public may also
file written statements before or after the
meeting to external@exim.gov.
Interested parties may register for the
TIME AND DATE:
E:\FR\FM\04NON1.SGM
04NON1
]]>Agencies
- EQUAL EMPLOYMENT OPPORTUNITY COMMMISSION
[Federal Register Volume 85, Number 214 (Wednesday, November 4, 2020)]
[Notices]
[Page 70149]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-24560]
=======================================================================
-----------------------------------------------------------------------
EQUAL EMPLOYMENT OPPORTUNITY COMMMISSION
Sunshine Act Meeting
DATE AND TIME: Monday, November 9, 2020, 1:00 p.m. Eastern Time.
PLACE: Because of the COVID-19 pandemic, the meeting will be held as an
audio-only conference.
STATUS: The meeting will be open to the public.
MATTERS TO BE CONSIDERED: The following item will be considered at the
meeting:
Update to the Compliance Manual Section on Religious
Discrimination.
Note: (In addition to publishing notices on EEOC Commission
meetings in the Federal Register, the Commission also provides
information about Commission meetings on its website, www.eeoc.gov.,
and provides a recorded announcement a week in advance on future
Commission sessions.)
Please telephone (202) 663-7100 (voice) or email
[email protected] at any time for information on this
meeting.
CONTACT PERSON FOR MORE INFORMATION: Bernadette B. Wilson, Executive
Officer on (202) 663-4077.
Raymond L. Peeler,
Assistant Legal Counsel, Office of Legal Counsel.
[FR Doc. 2020-24560 Filed 11-2-20; 11:15 am]
BILLING CODE 6570-01-P
